SeaStar Medical
47 hedge funds and large institutions have $97.9M invested in SeaStar Medical in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
6% more capital invested
Capital invested by funds: $92.2M → $97.9M (+$5.68M)
0.01% more ownership
Funds ownership: 0.36% → 0.37% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 50 → 47 (-3)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$2.24M |
| 2 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$304K |
| 3 |
Millennium Management
New York
|
+$165K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$96.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSC
Logan Stone Capital
Chicago,
Illinois
|
-$235K |
| 2 |
CC
Centiva Capital
New York
|
-$119K |
| 3 |
MSU
Mizuho Securities USA
New York
|
-$119K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$118K |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$117K |
ICU Hedge Fund Activity: Q2 2022 in Review
47 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q2 2022, worth a combined $97.9M — up 6.2% from $92.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ICU and 1 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Meteora Capital, opening a new position worth an estimated $2.24M. The largest seller was Logan Stone Capital, exiting entirely with an estimated $235K sold.
- 47 institutional investors held SeaStar Medical (ICU) as of Q2 2022, down from 50 in Q1 2022.
- Funds reported $97.9M of SeaStar Medical stock for Q2 2022, up 6.2% quarter-over-quarter.
- 1 fund opened new SeaStar Medical positions in Q2 2022 and 4 closed out, a net change of -3 holders.
- The largest SeaStar Medical buyer in Q2 2022 was Meteora Capital, an estimated $2.24M added.
- The largest SeaStar Medical seller in Q2 2022 was Logan Stone Capital, an estimated $235K sold.
Based on aggregated 13F filings for Q2 2022.